Ovid Therapeutics (OVID) Amortizatization of Intangibles (2022 - 2025)
Ovid Therapeutics' Amortizatization of Intangibles history spans 4 years, with the latest figure at $305000.0 for Q4 2025.
- For Q4 2025, Amortizatization of Intangibles rose 8.16% year-over-year to $305000.0; the TTM value through Dec 2025 reached $1.2 million, up 8.2%, while the annual FY2025 figure was $1.2 million, 8.2% up from the prior year.
- Amortizatization of Intangibles reached $305000.0 in Q4 2025 per OVID's latest filing, up from $300000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $354185.0 in Q2 2022 to a low of $253000.0 in Q1 2023.
- Average Amortizatization of Intangibles over 4 years is $278740.0, with a median of $272000.0 recorded in 2024.
- Peak YoY movement for Amortizatization of Intangibles: fell 27.16% in 2023, then increased 8.3% in 2025.
- A 4-year view of Amortizatization of Intangibles shows it stood at $254970.0 in 2022, then increased by 2.36% to $261000.0 in 2023, then rose by 8.05% to $282000.0 in 2024, then rose by 8.16% to $305000.0 in 2025.
- Per Business Quant, the three most recent readings for OVID's Amortizatization of Intangibles are $305000.0 (Q4 2025), $300000.0 (Q3 2025), and $294000.0 (Q2 2025).